UniDoc Announces Purchase Agreement for AGNES Connect Software from AMD Telemedicine
UniDoc Health Corp (OTCQB:UDOCF) has entered into a definitive purchase agreement to acquire AGNES Connect software from AMD Telemedicine for US$175,000 plus revenue share. The acquisition, expected to close shortly, includes the AMD Telemedicine name, related goodwill, software, intellectual property, trademarks, and customer subscriptions.
AGNES Connect is a secure cloud-based clinical examination platform that enables healthcare providers to exchange medical data, documents, and images in real-time with video conferencing capabilities. The software integrates with healthcare facilities' electronic health record (EHR) systems and will enhance UniDoc's NEIL Connect platform.
The NEIL Connect platform, integrated with Carefluence and DocBox software, leverages AI for intake/triage through MediOrbis and patient monitoring via DocBox. The platform maintains HIPAA compliance and ensures secure management of patient information.
UniDoc Health Corp (OTCQB:UDOCF) ha stipulato un accordo di acquisto definitivo per acquisire il software AGNES Connect da AMD Telemedicine per 175.000 dollari USA più una quota sui ricavi. L'acquisizione, che dovrebbe chiudersi a breve, include il nome di AMD Telemedicine, il goodwill correlato, il software, la proprietà intellettuale, i marchi e gli abbonamenti dei clienti.
AGNES Connect è una piattaforma di esame clinico sicura basata su cloud che consente ai fornitori di assistenza sanitaria di scambiare dati medici, documenti e immagini in tempo reale con funzionalità di videoconferenza. Il software si integra con i sistemi di registrazione elettronica della salute (EHR) delle strutture sanitarie e migliorerà la piattaforma NEIL Connect di UniDoc.
La piattaforma NEIL Connect, integrata con i software Carefluence e DocBox, sfrutta l'IA per l'accoglienza/trattamento attraverso MediOrbis e il monitoraggio dei pazienti tramite DocBox. La piattaforma mantiene la conformità HIPAA e garantisce una gestione sicura delle informazioni sui pazienti.
UniDoc Health Corp (OTCQB:UDOCF) ha firmado un acuerdo de compra definitivo para adquirir el software AGNES Connect de AMD Telemedicine por 175,000 dólares estadounidenses más una participación en los ingresos. Se espera que la adquisición se cierre en breve e incluye el nombre de AMD Telemedicine, el goodwill relacionado, el software, la propiedad intelectual, las marcas registradas y las suscripciones de los clientes.
AGNES Connect es una plataforma de examen clínico segura basada en la nube que permite a los proveedores de atención médica intercambiar datos médicos, documentos e imágenes en tiempo real con capacidades de videoconferencia. El software se integra con los sistemas de registros electrónicos de salud (EHR) de las instalaciones de atención médica y mejorará la plataforma NEIL Connect de UniDoc.
La plataforma NEIL Connect, integrada con los software Carefluence y DocBox, utiliza IA para la admisión/triaje a través de MediOrbis y el monitoreo de pacientes a través de DocBox. La plataforma mantiene la conformidad con HIPAA y garantiza una gestión segura de la información del paciente.
UniDoc Health Corp (OTCQB:UDOCF)는 AMD Telemedicine으로부터 AGNES Connect 소프트웨어를 175,000달러에 구매하는 최종 계약을 체결했습니다. 이 인수는 곧 완료될 예정이며, AMD Telemedicine의 이름, 관련 영업권, 소프트웨어, 지적 재산권, 상표 및 고객 구독을 포함합니다.
AGNES Connect는 실시간 비디오 회의 기능이 있는 안전한 클라우드 기반 임상 검사 플랫폼으로, 의료 제공자가 의료 데이터, 문서 및 이미지를 실시간으로 교환할 수 있게 해줍니다. 이 소프트웨어는 의료 시설의 전자 건강 기록(EHR) 시스템과 통합되며 UniDoc의 NEIL Connect 플랫폼을 향상시킬 것입니다.
NEIL Connect 플랫폼은 Carefluence 및 DocBox 소프트웨어와 통합되어 있으며, MediOrbis를 통해 수집/분류를 위한 AI를 활용하고 DocBox를 통해 환자 모니터링을 수행합니다. 이 플랫폼은 HIPAA 준수를 유지하며 환자 정보의 안전한 관리를 보장합니다.
UniDoc Health Corp (OTCQB:UDOCF) a conclu un accord d'achat définitif pour acquérir le logiciel AGNES Connect d'AMD Telemedicine pour 175 000 dollars américains, plus une part des revenus. L'acquisition, qui devrait être finalisée sous peu, inclut le nom d'AMD Telemedicine, le goodwill associé, le logiciel, la propriété intellectuelle, les marques et les abonnements des clients.
AGNES Connect est une plateforme d'examen clinique sécurisée basée sur le cloud qui permet aux prestataires de soins de santé d'échanger des données médicales, des documents et des images en temps réel avec des capacités de vidéoconférence. Le logiciel s'intègre aux systèmes de dossiers de santé électroniques (DSE) des établissements de santé et améliorera la plateforme NEIL Connect de UniDoc.
La plateforme NEIL Connect, intégrée avec les logiciels Carefluence et DocBox, utilise l'IA pour l'accueil/la triage via MediOrbis et le suivi des patients via DocBox. La plateforme respecte les normes HIPAA et garantit une gestion sécurisée des informations sur les patients.
UniDoc Health Corp (OTCQB:UDOCF) hat einen endgültigen Kaufvertrag unterzeichnet, um die AGNES Connect Software von AMD Telemedicine für 175.000 US-Dollar zu erwerben, zuzüglich einer Umsatzbeteiligung. Der Erwerb, der in Kürze abgeschlossen werden soll, umfasst den Namen AMD Telemedicine, das damit verbundene Goodwill, die Software, das geistige Eigentum, Marken und Kundenabonnements.
AGNES Connect ist eine sichere cloudbasierte klinische Untersuchungsplattform, die es Gesundheitsdienstleistern ermöglicht, medizinische Daten, Dokumente und Bilder in Echtzeit mit Videokonferenzfunktionen auszutauschen. Die Software integriert sich in die elektronischen Gesundheitsakten (EHR) der Gesundheitseinrichtungen und wird die NEIL Connect-Plattform von UniDoc verbessern.
Die NEIL Connect-Plattform, die mit den Softwarelösungen Carefluence und DocBox integriert ist, nutzt KI für die Aufnahme/Triage über MediOrbis und die Patientenüberwachung über DocBox. Die Plattform gewährleistet die Einhaltung der HIPAA-Vorgaben und sichert die sichere Verwaltung von Patienteninformationen.
- Immediate access to existing AGNES Connect customer base and revenue streams
- Enhanced software capabilities through secure data-sharing and EMR integration
- Strategic acquisition strengthens AI-driven telehealth offering
- Relatively low cash acquisition cost of US$175,000
- Additional revenue share payment structure could impact future profitability
- Acquisition subject to regulatory approval and closing conditions
- Integration costs and risks associated with merging software platforms
Strategic Acquisition to Enhance UniDoc's eHealth Software Capabilities
VANCOUVER, BC / ACCESS Newswire / March 19, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company"), an innovator in the eHealth sector, is pleased to announce it has entered into a definitive purchase agreement (the "Agreement") for the acquisition of the AGNES Connect software from AMD Telemedicine ("AMD"). This software forms the foundation of UniDoc's previously announced NEIL Connect software platform.
Highlights of proposed acquisition of AGNES Connect:
Accelerates the expansion and enhancement of UniDoc's NEIL Connect software platform.
UniDoc gains immediate access to existing AGNES Connect customers and plans continued support and expansion of this client base.
Strengthens UniDoc's integrated AI-driven telehealth offering with secure data-sharing and EMR integration capabilities.
AGNES Connect, is a secure, encrypted, cloud-based clinical examination platform recognized for its robust telemedicine capabilities. The software enables healthcare providers to capture and securely exchange medical data, documents, and images in real-time alongside high-quality video conferencing. AGNES Connect seamlessly integrates into healthcare facilities' electronic health record (EHR) systems, simplifying clinical workflows and documentation.
Pursuant to the terms of the Agreement effective March 18, 2025, UniDoc has agreed with AMD to acquire the name "AMD Telemedicine" and related goodwill, together with the AGNES Connect software and related intellectual property, trademarks, customer subscriptions and accounts. As consideration, the Company has agreed to pay AMD US
UniDoc CEO Antonio Baldassarre notes, "The proposed acquisition of AGNES Connect will strengthen our NEIL Connect platform, and position UniDoc to deliver a more comprehensive and seamless eHealth solution. This integration will immediately enhance our software capabilities and provide direct access to an established customer network, presenting new opportunities to generate sustainable revenue and enhance shareholder value."
UniDoc, upon closing of the acquisition, intends to continue to support and expand the existing AGNES Connect customer base, delivering improved software updates and enhanced customer service. The NEIL Connect platform is currently integrated with partners Carefluence and DocBox software, and leverages advanced artificial intelligence (AI) to facilitate more accurate intake/triage (MediOrbis) and more efficient patient monitoring (DocBox), further supporting UniDoc's mission to bridge gaps in healthcare accessibility and quality.
Ensuring strict adherence to healthcare data protection standards, UniDoc's NEIL Connect platform that supports compliance with the Health Insurance Portability and Accountability Act (HIPAA). Patient information is securely managed, encrypted, and integrated with hospital and clinical databases, aligning with industry-leading security practices and standards.
UniDoc is committed to further enhancing its telehealth solutions through continuous innovation and strategic growth initiatives, and anticipates leveraging AGNES Connect software once acquired to increase operational efficiencies and drive greater shareholder value.
On Behalf of the Board of Directors,
~Antonio Baldassarre~
Antonio Baldassarre
CEO, President & Director
UniDoc Health Corp.
About UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF)
UniDoc is developing an eHealth solution which is being designed as a self-contained remote virtual clinic within a private kiosk for patients to undergo full consultations as if they were present in a physician's office. eHealth opens the doors to a large segment of the population challenged by access, experience or understanding of online computer technology. It is the Company's belief that physical accessibility is the key to its business proposition. UniDoc is dedicated to unlocking shareholder value by delivering an excellent product and sophisticated commercial network within an expedited timeframe. The UniDoc team encourages engagement, questions, and interest, so please stay in touch and invite anyone who might be interested in our story to visit our website at www.unidoctor.com and signup to receive the latest information with updates on our activities, events and progress.
For further information, please contact:
UniDoc Investor Relations
Tel: +1 778.383.6731
Email: info@unidoctor.com
Matt Chatterton, Director
Tel: +1 778.613.2082
Email: matt@unidoctor.com
Media Inquiries media@unidoctor.com
Forward-Looking Statements
This news release contains statements and information that, to the extent that they are not historical fact, may constitute "forward-looking information" within the meaning of applicable securities legislation. Forward-looking information may include financial and other projections, as well as statements regarding future plans, objectives, or economic performance, or the assumption underlying any of the foregoing. In some cases, forward-looking statements can be identified by terms such as "may", "would", "could", "will", "will be", "likely", "except", "anticipate", "believe", "intend", "plan", "forecast", "project", "estimate", "outlook", or the negative thereof or other similar expressions concerning matters that are not historical facts. Examples of such statements include, but are not limited to, statements with respect to the highlights of the proposed acquisition of AGNES Connect, the expansion and enhancement of UniDoc's NEIL Connect software platform; closing of the acquisition and the timing thereof; the acquisition of the AGNES Connect software and its impact on the business of the Company; the Company continuing to support and expand the existing AGNES Connect customer base, and delivering improved software updates and enhanced customer service; the acquisition of the AGNES Connect customer base and accounts, the possible expansion of customer accounts; the Company enhancing shareholder value, generating sustainable growth, increasing operational efficiencies and bridging gaps in healthcare accessibility and quality; and the benefits the NEIL Connect software will add to the Company's products and that it will allow doctors to improve the accuracy of their diagnoses.
Forward-looking information is based on the assumptions, estimates, analysis, and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. The material factors and assumptions used to develop the forward-looking information contained in this news release include, but are not limited to, key personnel and qualified employees continuing their involvement with the Company; the Company's ability to secure additional financing on reasonable terms; the competitive conditions of the industries in which the Company operates; and laws and any amendments thereto applicable to the Company.
Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to secure financing on reasonable terms or at all; as well as all of the other risks as described in the Company's annual management discussion and analysis dated July 31, 2024 under the heading "Risks Factors." Accordingly, readers should not place undue reliance on any such forward-looking information.
Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company's management to predict all such factors and to assess in advance the impact of each such factor on the Company's business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward-looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law, including securities laws.
The CSE does not accept responsibility for the adequacy or accuracy of this release.
SOURCE: UniDoc Health Corp.
View the original press release on ACCESS Newswire
FAQ
What is the purchase price for AGNES Connect software acquisition by UDOCF?
What capabilities will AGNES Connect add to UniDoc's NEIL Connect platform?
When is the UDOCF acquisition of AGNES Connect expected to close?
How will the AGNES Connect acquisition benefit UDOCF shareholders?
